33796852|t|Fronto-temporal dementia risk gene TMEM106B has opposing effects in different lysosomal storage disorders.
33796852|a|TMEM106B is a transmembrane protein localized to the endo-lysosomal compartment. Genome-wide association studies have identified TMEM106B as a risk modifier of Alzheimer's disease and frontotemporal lobar degeneration, especially with progranulin haploinsufficiency. We recently demonstrated that TMEM106B loss rescues progranulin null mouse phenotypes including lysosomal enzyme dysregulation, neurodegeneration and behavioural alterations. However, the reason whether TMEM106B is involved in other neurodegenerative lysosomal diseases is unknown. Here, we evaluate the potential role of TMEM106B in modifying the progression of lysosomal storage disorders using progranulin-independent models of Gaucher disease and neuronal ceroid lipofuscinosis. To study Gaucher disease, we employ a pharmacological approach using the inhibitor conduritol B epoxide in wild-type and hypomorphic Tmem106b-/- mice. TMEM106B depletion ameliorates neuronal degeneration and some behavioural abnormalities in the pharmacological model of Gaucher disease, similar to its effect on certain progranulin null phenotypes. In order to examine the role of TMEM106B in neuronal ceroid lipofuscinosis, we crossbred Tmem106b-/- mice with Ppt1-/-, a genetic model of the disease. In contrast to its conduritol B epoxide-rescuing effect, TMEM106B loss exacerbates Purkinje cell degeneration and motor deficits in Ppt1-/- mice. Mechanistically, TMEM106B is known to interact with subunits of the vacuolar ATPase and influence lysosomal acidification. In the pharmacological Gaucher disease model, the acidified lysosomal compartment is enhanced and TMEM106B loss rescues in vivo phenotypes. In contrast, gene-edited neuronal loss of Ppt1 causes a reduction in vacuolar ATPase levels and impairment of the acidified lysosomal compartment, and TMEM106B deletion exacerbates the mouse Ppt1-/- phenotype. Our findings indicate that TMEM106B differentially modulates the progression of the lysosomal storage disorders Gaucher disease and neuronal ceroid lipofuscinosis. The effect of TMEM106B in neurodegeneration varies depending on vacuolar ATPase state and modulation of lysosomal pH. These data suggest TMEM106B as a target for correcting lysosomal pH alterations, and in particular for therapeutic intervention in Gaucher disease and neuronal ceroid lipofuscinosis.
33796852	0	24	Fronto-temporal dementia	Disease	MESH:D003704
33796852	35	43	TMEM106B	Gene	71900
33796852	78	105	lysosomal storage disorders	Disease	MESH:D016464
33796852	107	115	TMEM106B	Gene	71900
33796852	236	244	TMEM106B	Gene	71900
33796852	267	286	Alzheimer's disease	Disease	MESH:D000544
33796852	291	324	frontotemporal lobar degeneration	Disease	MESH:D057174
33796852	342	353	progranulin	Gene	14824
33796852	404	412	TMEM106B	Gene	71900
33796852	426	437	progranulin	Gene	14824
33796852	443	448	mouse	Species	10090
33796852	470	500	lysosomal enzyme dysregulation	Disease	MESH:D016464
33796852	502	519	neurodegeneration	Disease	MESH:D019636
33796852	577	585	TMEM106B	Gene	71900
33796852	607	643	neurodegenerative lysosomal diseases	Disease	MESH:D019636
33796852	696	704	TMEM106B	Gene	71900
33796852	737	764	lysosomal storage disorders	Disease	MESH:D016464
33796852	771	782	progranulin	Gene	14824
33796852	805	820	Gaucher disease	Disease	MESH:D005776
33796852	825	855	neuronal ceroid lipofuscinosis	Disease	MESH:D009472
33796852	866	881	Gaucher disease	Disease	MESH:D005776
33796852	940	960	conduritol B epoxide	Chemical	MESH:C011423
33796852	990	998	Tmem106b	Gene	71900
33796852	1002	1006	mice	Species	10090
33796852	1008	1016	TMEM106B	Gene	71900
33796852	1039	1060	neuronal degeneration	Disease	MESH:D009410
33796852	1082	1095	abnormalities	Disease	MESH:D000014
33796852	1128	1143	Gaucher disease	Disease	MESH:D005776
33796852	1178	1189	progranulin	Gene	14824
33796852	1239	1247	TMEM106B	Gene	71900
33796852	1251	1281	neuronal ceroid lipofuscinosis	Disease	MESH:D009472
33796852	1296	1304	Tmem106b	Gene	71900
33796852	1308	1312	mice	Species	10090
33796852	1318	1322	Ppt1	Gene	19063
33796852	1378	1398	conduritol B epoxide	Chemical	MESH:C011423
33796852	1416	1424	TMEM106B	Gene	71900
33796852	1442	1468	Purkinje cell degeneration	Disease	MESH:D002292
33796852	1473	1478	motor	Disease	MESH:D000068079
33796852	1491	1495	Ppt1	Gene	19063
33796852	1499	1503	mice	Species	10090
33796852	1522	1530	TMEM106B	Gene	71900
33796852	1651	1666	Gaucher disease	Disease	MESH:D005776
33796852	1726	1734	TMEM106B	Gene	71900
33796852	1810	1814	Ppt1	Gene	19063
33796852	1919	1927	TMEM106B	Gene	71900
33796852	1953	1958	mouse	Species	10090
33796852	1959	1963	Ppt1	Gene	19063
33796852	2005	2013	TMEM106B	Gene	71900
33796852	2062	2089	lysosomal storage disorders	Disease	MESH:D016464
33796852	2090	2105	Gaucher disease	Disease	MESH:D005776
33796852	2110	2140	neuronal ceroid lipofuscinosis	Disease	MESH:D009472
33796852	2156	2164	TMEM106B	Gene	71900
33796852	2168	2185	neurodegeneration	Disease	MESH:D019636
33796852	2279	2287	TMEM106B	Gene	71900
33796852	2391	2406	Gaucher disease	Disease	MESH:D005776
33796852	2411	2441	neuronal ceroid lipofuscinosis	Disease	MESH:D009472
33796852	Association	MESH:C011423	71900
33796852	Association	MESH:D009410	71900
33796852	Positive_Correlation	14824	71900
33796852	Association	MESH:D009472	71900
33796852	Association	MESH:D000544	71900
33796852	Association	MESH:D005776	71900
33796852	Association	19063	71900
33796852	Association	MESH:D016464	14824
33796852	Association	MESH:D019636	14824
33796852	Association	MESH:D005776	14824
33796852	Association	MESH:D016464	71900
33796852	Association	MESH:D003704	71900
33796852	Association	MESH:D000068079	71900
33796852	Positive_Correlation	MESH:D002292	71900
33796852	Association	MESH:D057174	71900
33796852	Association	MESH:D019636	71900
33796852	Association	MESH:D000014	71900

